Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
ziprasidone hydrochloride monohydrate, Quantity: 90.6 mg
Viatris Pty Ltd
Ziprasidone hydrochloride
Capsule, hard
Excipient Ingredients: titanium dioxide; pregelatinised maize starch; lactose monohydrate; Gelatin; indigo carmine; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide
Oral
6 capsules (2x 40mg, 2x 60mg, 2x 80mg)
(S4) Prescription Only Medicine
ZELDOX (ziprasidone) is indicated for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy; as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar I disorder.
Visual Identification: No. 2 blue cap/white body capsule marked "Pfizer" & "ZDX 80".; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2007-02-13
Version: ujpzeldc11021 Supersedes: ujpzeldc10221 Page 1 of 25 AUSTRALIAN PRODUCT INFORMATION - ZELDOX (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) CAPSULES 1. NAME OF THE MEDICINE Ziprasidone hydrochloride monohydrate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ZELDOX capsules containing ziprasidone hydrochloride monohydrate equivalent to 20 mg, 40 mg, 60 mg or 80 mg ziprasidone. EXCIPIENT(S) WITH KNOWN EFFECT • Lactose monohydrate For the full list of excipients, see Section 6.1 - List of excipients. 3. PHARMACEUTICAL FORM ZELDOX is supplied for oral administration as capsules. ZELDOX 20 mg capsules: No.4 blue/white capsules, marked “Pfizer” and “ZDX 20”. ZELDOX 40 mg capsules: No.4 blue capsules, marked “Pfizer” and “ZDX 40”. ZELDOX 60 mg capsules: No.3 white capsules, marked “Pfizer” and “ZDX 60”. ZELDOX 80 mg capsules: No.2 blue/white capsules, marked “Pfizer” and “ZDX 80”. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ZELDOX (ziprasidone) is indicated: • for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy; _ _ • as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar I disorder. Version: ujpzeldc11021 Supersedes: ujpzeldc10221 Page 2 of 25 4.2 DOSE AND METHOD OF ADMINISTRATION USE OF ZELDOX CAPSULES For oral use. ZELDOX capsules should be taken with food and swallowed whole without chewing, crushing or opening beforehand. SCHIZOPHRENIA The recommended dose in treatment of schizophrenia is 40 mg twice daily taken with food. Daily dosage may subsequently be adjusted on the basis of individual clinical status up to 80 mg twice daily. Dosage adjustments, if indicated, should generally occur at intervals of not less than 2 days. The maximum recommended dose of 80 mg twice daily may be reached as early as Day 3 of treatment. Ziprasidone is effective in the treatment of acutely exacerbated patients and in maintaining the clinical imp Read the complete document